Brief: Genscript Biotech Posts FY Loss Of $428.0 Million
31/03/2023 02:16
March 31 (Reuters) - Genscript Biotech Corp 1548.HK :
* FY LOSS US$428.0 MILLION VERSUS LOSS US$518.3 MILLION
* FY REVENUE US$625.7 MILLION, UP OF 27.7%
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale